Coya Therapeutics to Present Biomarker and Preliminary Efficacy Clinical Data for COYA 301 for the Treatment of Patients with Alzheimer’s Disease (AD) at the 2023 Keystone Symposia Meeting for Neurodegeneration held on May 15-19th, 2023 - Allele Capital

https://ir.coyatherapeutics.com/news/news-details/2023/Coya-Therapeutics-to-Present-Biomarker-and-Preliminary-Efficacy-Clinical-Data-for-COYA-301-for-the-Treatment-of-Patients-with-Alzheimers-Disease-AD-at-the-2023-Keystone-Symposia-Meeting-for-Neurodegeneration-held-on-May-15-19th-2023/default.aspx